# Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients

> **NCT01114165** · PHASE4 · COMPLETED · sponsor: **University Hospital Muenster** · enrollment: 150 (actual)

## Conditions studied

- Hematologic Diseases
- Neutropenia
- Febrile Neutropenia
- Sepsis

## Interventions

- **OTHER:** Detection of microbial DNA in blood by SeptiFast Test
- **OTHER:** Pathogen detection by blood culture

## Key facts

- **NCT ID:** NCT01114165
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2012-12-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01114165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01114165, "Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01114165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*